Steve Finkbeiner, MD, PhD
Steve Finkbeiner’s lab studies a wide range of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Huntington’s, Alzheimer’s, and Parkinson’s diseases. Specifically, they are interested in understanding how neuronal activity elicits changes in gene expression that are important for learning and memory, and how genetic mutations lead to neuronal dysfunction and degeneration.
Gladstone Science Talks allow investigators to share the latest research from their laboratories. These talks are open to the broader Gladstone community.
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.